Costs and cost-effectiveness of malaria control interventions--a systematic review
- PMID: 22050911
- PMCID: PMC3229472
- DOI: 10.1186/1475-2875-10-337
Costs and cost-effectiveness of malaria control interventions--a systematic review
Abstract
Background: The control and elimination of malaria requires expanded coverage of and access to effective malaria control interventions such as insecticide-treated nets (ITNs), indoor residual spraying (IRS), intermittent preventive treatment (IPT), diagnostic testing and appropriate treatment. Decisions on how to scale up the coverage of these interventions need to be based on evidence of programme effectiveness, equity and cost-effectiveness.
Methods: A systematic review of the published literature on the costs and cost-effectiveness of malaria interventions was undertaken. All costs and cost-effectiveness ratios were inflated to 2009 USD to allow comparison of the costs and benefits of several different interventions through various delivery channels, across different geographical regions and from varying costing perspectives.
Results: Fifty-five studies of the costs and forty three studies of the cost-effectiveness of malaria interventions were identified, 78% of which were undertaken in sub-Saharan Africa, 18% in Asia and 4% in South America. The median financial cost of protecting one person for one year was $2.20 (range $0.88-$9.54) for ITNs, $6.70 (range $2.22-$12.85) for IRS, $0.60 (range $0.48-$1.08) for IPT in infants, $4.03 (range $1.25-$11.80) for IPT in children, and $2.06 (range $0.47-$3.36) for IPT in pregnant women. The median financial cost of diagnosing a case of malaria was $4.32 (range $0.34-$9.34). The median financial cost of treating an episode of uncomplicated malaria was $5.84 (range $2.36-$23.65) and the median financial cost of treating an episode of severe malaria was $30.26 (range $15.64-$137.87). Economies of scale were observed in the implementation of ITNs, IRS and IPT, with lower unit costs reported in studies with larger numbers of beneficiaries. From a provider perspective, the median incremental cost effectiveness ratio per disability adjusted life year averted was $27 (range $8.15-$110) for ITNs, $143 (range $135-$150) for IRS, and $24 (range $1.08-$44.24) for IPT.
Conclusions: A transparent evidence base on the costs and cost-effectiveness of malaria control interventions is provided to inform rational resource allocation by donors and domestic health budgets and the selection of optimal packages of interventions by malaria control programmes.
Figures
Similar articles
-
Cost-effectiveness of malaria control in sub-Saharan Africa.Lancet. 1999 Jul 31;354(9176):378-85. doi: 10.1016/s0140-6736(99)02141-8. Lancet. 1999. PMID: 10437867
-
Cost and cost-effectiveness of indoor residual spraying with pirimiphos-methyl in a high malaria transmission district of Mozambique with high access to standard insecticide-treated nets.Malar J. 2021 Mar 10;20(1):143. doi: 10.1186/s12936-021-03687-1. Malar J. 2021. PMID: 33691706 Free PMC article.
-
Costs and consequences of large-scale vector control for malaria.Malar J. 2008 Dec 17;7:258. doi: 10.1186/1475-2875-7-258. Malar J. 2008. PMID: 19091114 Free PMC article.
-
The evidence base on the cost-effectiveness of malaria control measures in Africa.Health Policy Plan. 1999 Dec;14(4):301-12. doi: 10.1093/heapol/14.4.301. Health Policy Plan. 1999. PMID: 10787646 Review.
-
Which delivery systems reach the poor? A review of equity of coverage of ever-treated nets, never-treated nets, and immunisation to reduce child mortality in Africa.Lancet Infect Dis. 2005 Nov;5(11):709-17. doi: 10.1016/S1473-3099(05)70269-3. Lancet Infect Dis. 2005. PMID: 16253888 Review.
Cited by
-
Evidence of high bed net usage from a list randomization experiments in rural Gambia.Malar J. 2020 Jul 13;19(1):248. doi: 10.1186/s12936-020-03322-5. Malar J. 2020. PMID: 32660475 Free PMC article.
-
Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact.Malar J. 2020 Jul 14;19(1):252. doi: 10.1186/s12936-020-03313-6. Malar J. 2020. PMID: 32664939 Free PMC article.
-
Equity in long-lasting insecticidal nets and indoor residual spraying for malaria prevention in a rural South Central Ethiopia.Malar J. 2016 Jul 16;15:366. doi: 10.1186/s12936-016-1425-0. Malar J. 2016. PMID: 27422024 Free PMC article. Clinical Trial.
-
Impact of insecticide-treated nets and indoor residual spraying on self-reported malaria prevalence among women of reproductive age in Ghana: implication for malaria control and elimination.Malar J. 2022 Apr 12;21(1):120. doi: 10.1186/s12936-022-04136-3. Malar J. 2022. PMID: 35413832 Free PMC article.
-
The economic case for combating malaria.Am J Trop Med Hyg. 2013 Nov;89(5):819-823. doi: 10.4269/ajtmh.12-0689. Am J Trop Med Hyg. 2013. PMID: 24197172 Free PMC article.
References
-
- WHO. World Malaria Report - 2010. Geneva: WHO;
-
- Flaxman AD, Fullman N, Otten MW, Menon M, Cibulskis RE, Ng M, Murray CJL, Lim SS. Rapid scaling up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: A systematic synthesis of supply, distribution, and household survey data. Plos Medicine. 2010;7:e1000328. doi: 10.1371/journal.pmed.1000328. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical